[Mechanism of vanillic acid against cardiac fibrosis induced by isoproterenol in mice based on Drp1/HK1/NLRP3 and mitochondrial apoptosis signaling pathways].

Q3 Pharmacology, Toxicology and Pharmaceutics
Hai-Bo He, Mian Wu, Jie Xu, Qian-Qian Xu, Fang-Zhu Wan, Hua-Qiao Zhong, Ji-Hong Zhang, Gang Zhou, Hui-Lin Qin, Hao-Ran Li, Hai-Ming Tang
{"title":"[Mechanism of vanillic acid against cardiac fibrosis induced by isoproterenol in mice based on Drp1/HK1/NLRP3 and mitochondrial apoptosis signaling pathways].","authors":"Hai-Bo He, Mian Wu, Jie Xu, Qian-Qian Xu, Fang-Zhu Wan, Hua-Qiao Zhong, Ji-Hong Zhang, Gang Zhou, Hui-Lin Qin, Hao-Ran Li, Hai-Ming Tang","doi":"10.19540/j.cnki.cjcmm.20240914.401","DOIUrl":null,"url":null,"abstract":"<p><p>This study investigated the effects and underlying mechanisms of vanillic acid(VA) against cardiac fibrosis(CF) induced by isoproterenol(ISO) in mice. Male C57BL/6J mice were randomly divided into control group, VA group(100 mg·kg~(-1), ig), ISO group(10 mg·kg~(-1), sc), ISO + VA group(10 mg·kg~(-1), sc + 100 mg·kg~(-1), ig), ISO + dynamin-related protein 1(Drp1) inhibitor(Mdivi-1) group(10 mg·kg~(-1), sc + 50 mg·kg~(-1), ip), and ISO + VA + Mdivi-1 group(10 mg·kg~(-1), sc + 100 mg·kg~(-1), ig + 50 mg·kg~(-1), ip). The treatment groups received the corresponding medications once daily for 14 consecutive days. On the day after the last administration, cardiac functions were evaluated, and serum and cardiac tissue samples were collected. These samples were analyzed for serum aspartate aminotransferase(AST), lactate dehydrogenase(LDH), creatine kinase-MB(CK-MB), cardiac troponin I(cTnI), reactive oxygen species(ROS), interleukin(IL)-1β, IL-4, IL-6, IL-10, IL-18, and tumor necrosis factor-α(TNF-α) levels, as well as cardiac tissue catalase(CAT), glutathione(GSH), malondialdehyde(MDA), myeloperoxidase(MPO), superoxide dismutase(SOD), total antioxidant capacity(T-AOC) activities, and cytochrome C levels in mitochondria and cytoplasm. Hematoxylin-eosin, Masson, uranium acetate and lead citrate staining were used to observe morphological and mitochondrial ultrastructural changes in the cardiac tissues, and myocardial injury area and collagen volume fraction were calculated. Flow cytometry was applied to detect the relative content and M1/M2 polarization of cardiac macrophages. The mRNA expression levels of macrophage polarization markers [CD86, CD206, arginase 1(Arg-1), inducible nitric oxide synthase(iNOS)], CF markers [type Ⅰ collagen(Coll Ⅰ), Coll Ⅲ, α-smooth muscle actin(α-SMA)], and cytokines(IL-1β, IL-4, IL-6, IL-10, IL-18, TNF-α) in cardiac tissues were determined by quantitative real-time PCR. Western blot was used to detect the protein expression levels of Coll Ⅰ, Coll Ⅲ, α-SMA, Drp1, p-Drp1, voltage-dependent anion channel(VDAC), hexokinase 1(HK1), NOD-like receptor protein 3(NLRP3), apoptosis-associated speck-like protein(ASC), caspase-1, cleaved-caspase-1, gasdermin D(GSDMD), cleaved N-terminal gasdermin D(GSDMD-N), IL-1β, IL-18, B-cell lymphoma-2(Bcl-2), B-cell lymphoma-xl(Bcl-xl), Bcl-2-associated death promoter(Bad), Bcl-2-associated X protein(Bax), apoptotic protease activating factor-1(Apaf-1), pro-caspase-3, cleaved-caspase-3, pro-caspase-9, cleaved-caspase-9, poly(ADP-ribose) polymerase-1(PARP-1), and cleaved-PARP-1 in cardiac tissues. The results showed that VA significantly improved cardiac function in mice with CF, reduced myocardial injury area and cardiac index, and decreased serum levels of AST, CK-MB, cTnI, LDH, ROS, IL-1β, IL-6, IL-18, and TNF-α. VA also lowered MDA and MPO levels, mRNA expressions of IL-1β, IL-6, IL-18, and TNF-α, and mRNA and protein expressions of Coll Ⅰ, Coll Ⅲ, and α-SMA in cardiac tissues, and increased serum levels of IL-4 and IL-10, cardiac tissue levels of CAT, GSH, SOD, and T-AOC, and mRNA expressions of IL-4 and IL-10. Additionally, VA ameliorated cardiac pathological damage, inhibited myocardial cell apoptosis, inflammatory infiltration, and collagen fiber deposition, reduced collagen volume fraction, and alleviated mitochondrial damage. VA decreased the ratio of F4/80~+CD86~+ M1 cells and the mRNA expressions of CD86 and iNOS in cardiac tissue, and increased the ratio of F4/80~+CD206~+ M2 cells and the mRNA expressions of CD206 and Arg-1. VA also reduced protein expressions of p-Drp1, VDAC, NLRP3, ASC, caspase-1, cleaved-caspase-1, GSDMD, GSDMD-N, IL-1β, IL-18, Bad, Bax, Apaf-1, cleaved-caspase-3, cleaved-caspase-9, cleaved-PARP-1, and cytoplasmic cytochrome C, and increased the expressions of HK1, Bcl-2, Bcl-xl, pro-caspase-3, pro-caspase-9 proteins, as well as the Bcl-2/Bax and Bcl-xl/Bad ratios and mitochondrial cytochrome C content. These results indicate that VA has a significant ameliorative effect on ISO-induced CF in mice, alleviates ISO-induced oxidative damage and inflammatory response, and its mechanism may be closely related to the inhibition of Drp1/HK1/NLRP3 and mitochondrial apoptosis signaling pathways, suppression of myocardial cell inflammatory infiltration and collagen fiber deposition, reduction of collagen volume fraction and CollⅠ, Coll Ⅲ, and α-SMA expressions, thus mitigating CF.</p>","PeriodicalId":52437,"journal":{"name":"Zhongguo Zhongyao Zazhi","volume":"50 8","pages":"2193-2208"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhongguo Zhongyao Zazhi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19540/j.cnki.cjcmm.20240914.401","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

This study investigated the effects and underlying mechanisms of vanillic acid(VA) against cardiac fibrosis(CF) induced by isoproterenol(ISO) in mice. Male C57BL/6J mice were randomly divided into control group, VA group(100 mg·kg~(-1), ig), ISO group(10 mg·kg~(-1), sc), ISO + VA group(10 mg·kg~(-1), sc + 100 mg·kg~(-1), ig), ISO + dynamin-related protein 1(Drp1) inhibitor(Mdivi-1) group(10 mg·kg~(-1), sc + 50 mg·kg~(-1), ip), and ISO + VA + Mdivi-1 group(10 mg·kg~(-1), sc + 100 mg·kg~(-1), ig + 50 mg·kg~(-1), ip). The treatment groups received the corresponding medications once daily for 14 consecutive days. On the day after the last administration, cardiac functions were evaluated, and serum and cardiac tissue samples were collected. These samples were analyzed for serum aspartate aminotransferase(AST), lactate dehydrogenase(LDH), creatine kinase-MB(CK-MB), cardiac troponin I(cTnI), reactive oxygen species(ROS), interleukin(IL)-1β, IL-4, IL-6, IL-10, IL-18, and tumor necrosis factor-α(TNF-α) levels, as well as cardiac tissue catalase(CAT), glutathione(GSH), malondialdehyde(MDA), myeloperoxidase(MPO), superoxide dismutase(SOD), total antioxidant capacity(T-AOC) activities, and cytochrome C levels in mitochondria and cytoplasm. Hematoxylin-eosin, Masson, uranium acetate and lead citrate staining were used to observe morphological and mitochondrial ultrastructural changes in the cardiac tissues, and myocardial injury area and collagen volume fraction were calculated. Flow cytometry was applied to detect the relative content and M1/M2 polarization of cardiac macrophages. The mRNA expression levels of macrophage polarization markers [CD86, CD206, arginase 1(Arg-1), inducible nitric oxide synthase(iNOS)], CF markers [type Ⅰ collagen(Coll Ⅰ), Coll Ⅲ, α-smooth muscle actin(α-SMA)], and cytokines(IL-1β, IL-4, IL-6, IL-10, IL-18, TNF-α) in cardiac tissues were determined by quantitative real-time PCR. Western blot was used to detect the protein expression levels of Coll Ⅰ, Coll Ⅲ, α-SMA, Drp1, p-Drp1, voltage-dependent anion channel(VDAC), hexokinase 1(HK1), NOD-like receptor protein 3(NLRP3), apoptosis-associated speck-like protein(ASC), caspase-1, cleaved-caspase-1, gasdermin D(GSDMD), cleaved N-terminal gasdermin D(GSDMD-N), IL-1β, IL-18, B-cell lymphoma-2(Bcl-2), B-cell lymphoma-xl(Bcl-xl), Bcl-2-associated death promoter(Bad), Bcl-2-associated X protein(Bax), apoptotic protease activating factor-1(Apaf-1), pro-caspase-3, cleaved-caspase-3, pro-caspase-9, cleaved-caspase-9, poly(ADP-ribose) polymerase-1(PARP-1), and cleaved-PARP-1 in cardiac tissues. The results showed that VA significantly improved cardiac function in mice with CF, reduced myocardial injury area and cardiac index, and decreased serum levels of AST, CK-MB, cTnI, LDH, ROS, IL-1β, IL-6, IL-18, and TNF-α. VA also lowered MDA and MPO levels, mRNA expressions of IL-1β, IL-6, IL-18, and TNF-α, and mRNA and protein expressions of Coll Ⅰ, Coll Ⅲ, and α-SMA in cardiac tissues, and increased serum levels of IL-4 and IL-10, cardiac tissue levels of CAT, GSH, SOD, and T-AOC, and mRNA expressions of IL-4 and IL-10. Additionally, VA ameliorated cardiac pathological damage, inhibited myocardial cell apoptosis, inflammatory infiltration, and collagen fiber deposition, reduced collagen volume fraction, and alleviated mitochondrial damage. VA decreased the ratio of F4/80~+CD86~+ M1 cells and the mRNA expressions of CD86 and iNOS in cardiac tissue, and increased the ratio of F4/80~+CD206~+ M2 cells and the mRNA expressions of CD206 and Arg-1. VA also reduced protein expressions of p-Drp1, VDAC, NLRP3, ASC, caspase-1, cleaved-caspase-1, GSDMD, GSDMD-N, IL-1β, IL-18, Bad, Bax, Apaf-1, cleaved-caspase-3, cleaved-caspase-9, cleaved-PARP-1, and cytoplasmic cytochrome C, and increased the expressions of HK1, Bcl-2, Bcl-xl, pro-caspase-3, pro-caspase-9 proteins, as well as the Bcl-2/Bax and Bcl-xl/Bad ratios and mitochondrial cytochrome C content. These results indicate that VA has a significant ameliorative effect on ISO-induced CF in mice, alleviates ISO-induced oxidative damage and inflammatory response, and its mechanism may be closely related to the inhibition of Drp1/HK1/NLRP3 and mitochondrial apoptosis signaling pathways, suppression of myocardial cell inflammatory infiltration and collagen fiber deposition, reduction of collagen volume fraction and CollⅠ, Coll Ⅲ, and α-SMA expressions, thus mitigating CF.

[基于Drp1/HK1/NLRP3和线粒体凋亡信号通路的香草酸抗异丙肾上腺素诱导小鼠心肌纤维化的机制]。
本研究探讨了香草酸(VA)对异丙肾上腺素(ISO)诱导小鼠心脏纤维化(CF)的作用及其机制。将雄性C57BL/6J小鼠随机分为对照组、VA组(100 mg·kg~(-1), ig)、ISO组(10 mg·kg~(-1), sc)、ISO + VA组(10 mg·kg~(-1), sc + 100 mg·kg~(-1), ig)、ISO +动力蛋白相关蛋白1(Drp1)抑制剂(mdiv -1)组(10 mg·kg~(-1), sc + 50 mg·kg~(-1), ip)、ISO + VA + mdiv -1组(10 mg·kg~(-1), sc + 100 mg·kg~(-1), ig + 50 mg·kg~(-1), ip)。治疗组给予相应药物治疗,每天1次,连续14天。末次给药后第1天测定大鼠心功能,采集血清和心脏组织标本。检测血清天冬氨酸转氨酶(AST)、乳酸脱氢酶(LDH)、肌酸激酶- mb (CK-MB)、心肌肌钙蛋白I(cTnI)、活性氧(ROS)、白细胞介素(IL)-1β、IL-4、IL-6、IL-10、IL-18、肿瘤坏死因子-α(TNF-α)水平,以及心肌组织过氧化氢酶(CAT)、谷胱甘肽(GSH)、丙二醛(MDA)、髓过氧化物酶(MPO)、超氧化物歧化酶(SOD)、总抗氧化能力(T-AOC)活性。线粒体和细胞质中的细胞色素C水平。采用苏木精-伊红染色、马松染色、醋酸铀染色、柠檬酸铅染色观察大鼠心肌组织形态和线粒体超微结构变化,计算心肌损伤面积和胶原体积分数。流式细胞术检测心肌巨噬细胞相对含量及M1/M2极化。采用实时荧光定量PCR检测心肌组织巨噬细胞极化标记物[CD86、CD206、精氨酸酶1(Arg-1)、诱导型一氧化氮合酶(iNOS)]、CF标记物[Ⅰ型胶原(CollⅠ)、CollⅢ、α-平滑肌肌动蛋白(α-SMA)]和细胞因子(IL-1β、IL-4、IL-6、IL-10、IL-18、TNF-α) mRNA表达水平。Western blot检测CollⅠ、CollⅢ、α-SMA、Drp1、p-Drp1、电压依赖性阴离子通道(VDAC)、已糖激酶1(HK1)、nod样受体蛋白3(NLRP3)、凋亡相关斑点样蛋白(ASC)、caspase-1、裂解型caspase-1、gasdermin D(GSDMD)、裂解型n端gasdermin D(GSDMD- n)、IL-1β、IL-18、b细胞淋巴瘤-2(Bcl-2)、b细胞淋巴瘤-xl(Bcl-xl)、Bcl-2相关死亡启动子(Bad)、Bcl-2相关X蛋白(Bax)、凋亡蛋白酶激活因子-1(Apaf-1)、前caspase-3、切割-caspase-3、前caspase-9、切割-caspase-9、聚(adp核糖)聚合酶-1(PARP-1)和切割-PARP-1在心脏组织中的表达。结果表明,VA可显著改善CF小鼠心功能,减少心肌损伤面积和心脏指数,降低血清AST、CK-MB、cTnI、LDH、ROS、IL-1β、IL-6、IL-18和TNF-α水平。VA降低心肌组织MDA、MPO水平,IL-1β、IL-6、IL-18、TNF-α mRNA表达,CollⅠ、CollⅢ、α-SMA mRNA和蛋白表达,升高血清IL-4、IL-10水平,升高心肌组织CAT、GSH、SOD、T-AOC水平,升高IL-4、IL-10 mRNA表达。此外,VA可改善心脏病理损伤,抑制心肌细胞凋亡、炎症浸润和胶原纤维沉积,降低胶原体积分数,减轻线粒体损伤。VA降低心肌组织F4/80~+CD86~+ M1细胞比例及CD86、iNOS mRNA表达量,升高F4/80~+CD206~+ M2细胞比例及CD206、Arg-1 mRNA表达量。VA还降低了p-Drp1、VDAC、NLRP3、ASC、caspase-1、切割-caspase-1、GSDMD、GSDMD- n、IL-1β、IL-18、Bad、Bax、Apaf-1、切割-caspase-3、切割-caspase-9、切割- parp -1和细胞质细胞色素C的表达,增加了HK1、Bcl-2、Bcl-xl、pro-caspase-3、pro-caspase-9蛋白的表达,以及Bcl-2/Bax和Bcl-xl/Bad比值和线粒体细胞色素C含量。上述结果表明,VA对小鼠iso诱导的CF具有显著的改善作用,减轻了iso诱导的氧化损伤和炎症反应,其机制可能与抑制Drp1/HK1/NLRP3和线粒体凋亡信号通路,抑制心肌细胞炎症浸润和胶原纤维沉积,降低胶原体积分数和CollⅠ、CollⅢ、α-SMA表达,从而减轻CF密切相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Zhongguo Zhongyao Zazhi
Zhongguo Zhongyao Zazhi Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.50
自引率
0.00%
发文量
581
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信